↓ Skip to main content

Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma

Overview of attention for article published in PharmacoEconomics, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
52 Mendeley
Title
Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin’s Lymphoma
Published in
PharmacoEconomics, September 2012
DOI 10.2165/00019053-200927010-00006
Pubmed ID
Authors

Philippe Fagnoni, Noel Milpied, Samuel Limat, Eric Deconinck, Virginie Nerich, Charles Foussard, Philippe Colombat, Jean-Luc Harousseau, Marie-Christine Woronoff-Lemsi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Other 8 15%
Student > Bachelor 8 15%
Student > Ph. D. Student 6 12%
Researcher 6 12%
Student > Master 6 12%
Other 7 13%
Unknown 11 21%
Readers by discipline Count As %
Medicine and Dentistry 16 31%
Psychology 4 8%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Economics, Econometrics and Finance 3 6%
Other 7 13%
Unknown 16 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2016.
All research outputs
#8,535,472
of 25,374,917 outputs
Outputs from PharmacoEconomics
#996
of 1,992 outputs
Outputs of similar age
#64,665
of 189,085 outputs
Outputs of similar age from PharmacoEconomics
#227
of 548 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,085 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 548 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.